Related Experiment Videos
Enterolysin A, a cell wall-degrading bacteriocin from Enterococcus faecalis LMG 2333
Trine Nilsen1, Ingolf F Nes, Helge Holo
1Laboratory of Microbial Gene Technology, Agricultural University of Norway, N-1432 As, Norway. tnilsen@partners.org
Applied and Environmental Microbiology
|May 7, 2003
Summary
A novel antimicrobial protein, enterolysin A, was purified from Enterococcus faecalis. This bacteriocin exhibits bacteriolytic activity against various Gram-positive bacteria, offering potential as a therapeutic agent.
Area of Science:
- Microbiology
- Biochemistry
- Molecular Biology
Background:
- Enterococcus faecalis is an opportunistic pathogen.
- Bacteriocins are antimicrobial peptides with therapeutic potential.
- Novel antimicrobial agents are needed to combat resistant bacteria.
Purpose of the Study:
- To purify and characterize a novel antimicrobial protein from Enterococcus faecalis.
- To determine the structure and mode of action of enterolysin A.
- To evaluate the potential of enterolysin A as a therapeutic agent.
Main Methods:
- Purification of enterolysin A using chromatography.
- Determination of the primary structure by amino acid and DNA sequencing.
- Analysis of antimicrobial activity and mode of action.
Main Results:
- Enterolysin A was purified and characterized.
- The bacteriocin exhibits bacteriolytic activity against selected Gram-positive bacteria.
- Its N-terminus is homologous to M37 protease family endopeptidases.
Conclusions:
- Enterolysin A is a novel bacteriocin with a bacteriolytic mode of action.
- The protein has potential as a therapeutic agent against Gram-positive bacterial infections.
- Further research is warranted to explore its clinical applications.